Source: Annual Congress 2013 –Clinical studies in lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
H. Masquillier, R. Vos, D. Ruttens, S. Verleden, E. Vandermeulen, B. Vanaudenaerde, J. Yserbyt, L. Dupont, D. Van Raemdonck, G. Verleden (Leuven, Belgium). Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation. Eur Respir J 2013; 42: Suppl. 57, 2678

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment. Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Anastomotic airway complications after lung transplantation: Risk factors, treatment modalities and outcome: A single center experience Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Extracorporeal photopheresis in lung transplant:The initial experience in our hospital Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Lung transplantation in patients with prior or concurrent cancer: safety first? Source: International Congress 2017 – Difficult indications for lung transplantation Year: 2017 Current outcome after lung transplantation Source: Annual Congress 2012 - Lung transplantation in 2012: where are we? Year: 2012 Lung complications after liver transplantation in children: The Swiss experience Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Primary graft dysfunction after lung transplantation: Medium and long term outcomes Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX) Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation. Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Clinical impact of the complications related to lung transplantation Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Uncontrolled non-heart-beating donors vs. brain dead donors in lung transplantation: Comparison of early and late results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016